Celanese/$CE
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Celanese
Celanese is a global specialty chemicals manufacturer. It operates in two segments: acetyl chain, and engineered materials. Acetyl chain profitability is exposed to commodity-linked raw materials and product pricing spreads. Engineered materials converts basic chemicals into higher-margin specialty polymers and compounds engineered for specific customer applications in automotive, medical, electronics, and industrial end markets.
- Ticker
- $CE
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 11,434
- Headquarters
- Irving, United States
- Website
- www.celanese.com
Celanese Metrics
BasicAdvanced
$5.3B
-
-$10.66
0.76
$0.12
0.25%
Price and volume
Market cap
$5.3B
Beta
0.76
52-week high
$70.70
52-week low
$35.13
Average daily volume
1.7M
Dividend rate
$0.12
Financial strength
Current ratio
1.447
Quick ratio
0.807
Long term debt to equity
2.4
Total debt to equity
2.686
Interest coverage (TTM)
1.28%
Profitability
EBITDA (TTM)
1,600
Gross margin (TTM)
21.23%
Net profit margin (TTM)
-12.04%
Operating margin (TTM)
9.53%
Effective tax rate (TTM)
-1.96%
Revenue per employee (TTM)
$850,000
Management effectiveness
Return on assets (TTM)
2.57%
Return on equity (TTM)
-22.25%
Valuation
Price to revenue (TTM)
0.543
Price to book
1.27
Price to tangible book (TTM)
-1.73
Price to free cash flow (TTM)
7.447
Free cash flow yield (TTM)
13.43%
Free cash flow per share (TTM)
6.457
Dividend yield (TTM)
0.25%
Forward dividend yield
0.25%
Growth
Revenue change (TTM)
-2.17%
Earnings per share change (TTM)
-28.84%
3-year revenue growth (CAGR)
-1.93%
10-year revenue growth (CAGR)
5.85%
3-year earnings per share growth (CAGR)
-2.86%
10-year earnings per share growth (CAGR)
16.56%
3-year dividend per share growth (CAGR)
-64.92%
10-year dividend per share growth (CAGR)
-20.95%
What the Analysts think about Celanese
Analyst ratings (Buy, Hold, Sell) for Celanese stock.
Analyst projections of the future price of Celanese stock.
Bulls say / Bears say
Q2 adjusted EPS was $2.45, its highest in nearly three years, and Celanese maintained its 2026 outlook of about $6 adjusted EPS and $700–800 million of free cash flow. That gives the recovery case a near-term earnings and cash-generation anchor. (Celanese)
Medical and electronics showed momentum in Q2 and offer a higher-margin growth avenue: management said medical generates about 20% of Engineered Materials’ contribution margin on less than 10% of sales, while electronics generates 10–15% on about 10% of sales. Better mix in these niches could lift returns without relying only on broad volume growth. (The Motley Fool)
Footprint changes, including the Ulsan closure and nylon network optimisation, are expected to deliver more than $50 million in annual fixed-cost savings. If delivered, these savings should strengthen competitiveness and support earnings even as markets normalise. (Celanese)
Management expects Q3 adjusted EPS to fall to $1.35–$1.75 from $2.45 in Q2, citing moderation in supply-related opportunities, higher raw-material costs and costs linked to footprint changes. This highlights how much recent earnings relied on favourable conditions that may not last. (Celanese)
Debt remains a major constraint: at the end of June, Celanese had about $12.0 billion of total debt and incurred $186 million of interest expense in Q2. Its July credit amendment raised the leverage covenant to 5.50 times, underlining the pressure on its balance sheet and financial flexibility. (SEC, SEC)
Operating cash flow fell to $285 million in the first half from $447 million a year earlier, as receivables and inventory absorbed cash. That weaker conversion makes the $700–800 million full-year free-cash-flow target—and faster debt reduction—harder to achieve. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 19 Oct 2026.
Celanese Financial Performance
Revenues and expenses
Celanese Earnings Performance
Company profitability
Upcoming events
Celanese News
AllArticlesVideos
Funds containing Celanese
AllUSDEURGBP
Fund name | Fund size | $CE weighting |
|---|---|---|
iShares USD High Yield Corporate Bond€IS0R | $2.3B | 2.27% |
iShares USD High Yield Corporate Bond£SHYU | $2.3B | 2.27% |
iShares USD Short Duration High Yield Corporate Bond£SDHG | $959M | 1.59% |
iShares Global High Yield Corporate Bond$HYLD | $963M | 1.05% |
iShares Global High Yield Corporate Bond£IGHY | $963M | 1.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.